Brad H. Rovin

CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus

Hemant Kulkarni, M. Mamtani, P. Correa, 2007, Annals of the rheumatic diseases.

Monocyte chemoattractant protein-1 levels in patients with glomerular disease.

B. Rovin, L. Tan, N. Doe, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells.

B. Rovin, L. Tan, T. Yoshiumura, 1992, Journal of immunology.

The antiinflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis. The modulation of macrophage migration and eicosanoid metabolism.

B. Rovin, J. Lefkowith, G. Schreiner, 1989, Journal of immunology.

Differentiation‐dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins

M. Belury, D. Kniss, Xihai Kang, 2006, Diabetes, obesity & metabolism.

Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus

Kevin M. Wheelock, Jian Cai, E. Weil, 2017, PloS one.

Predicting decline of kidney function in lupus nephritis using urine biomarkers

R. Vasan, P. Kimmel, B. Rovin, 2016, Lupus.

Cyclopentenone prostaglandins inhibit cytokine-induced nf-kappab activation and chemokine production by human mesangial cells.

B. Rovin, A. Cosio, Ling Lu, 2001, Journal of the American Society of Nephrology : JASN.